CVSA vs. AZN
CVSA (Covista Inc.) and AZN (AstraZeneca PLC) are both stocks. CVSA operates in Education & Training Services (Consumer Defensive), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, CVSA returned 21.23%/yr vs 15.57%/yr for AZN. At a 0.16 correlation, their price movements are largely independent.
Performance
CVSA vs. AZN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CVSA achieves a 15.28% return, which is significantly higher than AZN's -2.03% return. Over the past 10 years, CVSA has outperformed AZN with an annualized return of 21.23%, while AZN has yielded a comparatively lower 15.57% annualized return.
CVSA
- 1D
- 0.18%
- 1M
- -4.69%
- YTD
- 15.28%
- 6M
- 16.11%
- 1Y
- -4.64%
- 3Y*
- 50.56%
- 5Y*
- 27.16%
- 10Y*
- 21.23%
AZN
- 1D
- 0.86%
- 1M
- -5.67%
- YTD
- -2.03%
- 6M
- -1.63%
- 1Y
- 29.64%
- 3Y*
- 9.46%
- 5Y*
- 11.29%
- 10Y*
- 15.57%
CVSA vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CVSA Covista Inc. | 15.28% | 13.89% | 54.11% | 66.06% | 20.09% | -12.93% | -2.92% | -26.10% | 12.53% | 34.78% |
AZN AstraZeneca PLC | -2.03% | 43.30% | -0.62% | 1.44% | 19.14% | 19.66% | 3.12% | 35.68% | 13.86% | 33.10% |
Correlation
The correlation between CVSA and AZN is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.03 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.09 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since May 17, 1993 | 0.16 |
The correlation between CVSA and AZN shifts across timeframes, from -0.00 (1 year) to 0.16 (all time), reflecting how their relationship changes across market environments.
Fundamentals
CVSA:
$4.15B
AZN:
$275.41B
CVSA:
$6.88
AZN:
$6.66
CVSA:
17.35
AZN:
26.51
CVSA:
0.56
AZN:
0.04
CVSA:
2.27
AZN:
4.56
CVSA:
3.04
AZN:
5.82
CVSA:
$1.91B
AZN:
$60.44B
CVSA:
$1.11B
AZN:
$49.37B
CVSA:
$431.35M
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CVSA vs. AZN — Risk / Return Rank
CVSA
AZN
CVSA vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Covista Inc. (CVSA) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CVSA | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.27 | ||
| Sortino ratioReturn per unit of downside risk | -1.73 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.22 | -0.18 |
| Calmar ratioReturn relative to maximum drawdown | -0.11 | 1.86 | -1.97 |
| Martin ratioReturn relative to average drawdown | -0.19 | 4.92 | -5.11 |
Loading charts...
Drawdowns
CVSA vs. AZN - Drawdown Comparison
The maximum CVSA drawdown since its inception was -77.26%, which is greater than AZN's maximum drawdown of -48.94%. Use the drawdown chart below to compare losses from any high point for CVSA and AZN.
Loading charts...
Drawdown Indicators
| CVSA | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -77.26% | -48.94% | -28.32% |
Max Drawdown (1Y)Largest decline over 1 year | -42.14% | -16.08% | -26.06% |
Max Drawdown (3Y)Largest decline over 3 years | -42.14% | -27.87% | -14.27% |
Max Drawdown (5Y)Largest decline over 5 years | -50.23% | -27.87% | -22.36% |
Max Drawdown (10Y)Largest decline over 10 years | -66.06% | -27.87% | -38.19% |
Current DrawdownCurrent decline from peak | -22.77% | -15.36% | -7.41% |
Average DrawdownAverage peak-to-trough decline | -30.66% | -11.37% | -19.29% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 24.41% | 6.06% | +18.35% |
Volatility
CVSA vs. AZN - Volatility Comparison
Covista Inc. (CVSA) has a higher volatility of 11.64% compared to AstraZeneca PLC (AZN) at 7.60%. This indicates that CVSA's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CVSA | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.64% | 7.60% | +4.04% |
Volatility (6M)Calculated over the trailing 6-month period | 28.88% | 17.62% | +11.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.51% | 25.53% | +21.98% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.30% | 24.07% | +18.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.52% | 24.92% | +14.60% |
Dividends
CVSA vs. AZN - Dividend Comparison
CVSA has not paid dividends to shareholders, while AZN's dividend yield for the trailing twelve months is around 3.02%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 3.02% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
CVSA Covista Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.15% | 1.42% |
Financials
CVSA vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between Covista Inc. and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CVSA vs. AZN - Profitability Comparison
CVSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Covista Inc. reported a gross profit of 290.93M and revenue of 487.03M. Therefore, the gross margin over that period was 59.7%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
CVSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Covista Inc. reported an operating income of 92.21M and revenue of 487.03M, resulting in an operating margin of 18.9%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
CVSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Covista Inc. reported a net income of 57.98M and revenue of 487.03M, resulting in a net margin of 11.9%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
CVSA and AZN have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CVSA has higher volatility (11.64%) compared to AZN (7.60%). In terms of maximum drawdown, CVSA dropped -77.26% vs AZN's -48.94%.
AZN currently has the higher Sharpe Ratio (1.17 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CVSA and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer